Which circulating level of 25-hydroxyvitamin D is appropriate?

Area of Science:

• Endocrinology
• Bone Metabolism
• Nutritional Science

Background:

• Vitamin D deficiency is linked to secondary hyperparathyroidism, bone loss, osteoporosis, and fractures.
• There is ongoing debate regarding the optimal circulating level of 25-hydroxyvitamin D (25OHD).
• Geographical variations in hip fracture incidence and serum 25(OH)D levels exist, with conflicting findings on its role as a risk factor.

Purpose of the Study:

• To determine the appropriate circulating level of 25-hydroxyvitamin D (25OHD).
• To investigate the relationship between serum 25(OH)D, parathyroid hormone (PTH), and bone health.
• To assess the influence of dietary calcium intake on Vitamin D metabolism and bone health.

Main Methods:

• Review of existing epidemiological studies and scientific literature.
• Analysis of the relationship between serum 25(OH)D levels and PTH response.
• Consideration of factors influencing Vitamin D metabolism, such as calcium intake.

Main Results:

• The threshold for parathyroid hormone (PTH) elevation varies significantly (30-78 nmol/l) across studies, potentially due to interlaboratory variations.
• Dietary calcium intake impacts PTH levels and Vitamin D metabolite turnover, with low calcium intake potentially worsening deficiency and high calcium intake having a sparing effect.
• International studies present conflicting data regarding the correlation between latitude, Vitamin D levels, and hip fracture risk.

Conclusions:

• A consensus serum 25-hydroxyvitamin D (25OHD) level of 50 nmol/l is proposed based on current knowledge.
• Further research is needed to clarify the optimal 25(OH)D levels and their relationship with bone health, considering factors like calcium intake and geographical variations.
• Standardization of laboratory assays is crucial for accurate assessment of 25(OH)D levels and their clinical interpretation.